BioAro Inc. to Donate Genomic Testing Free of Charge to 100 Prostate Cancer Centre Patients
Together they will change the way metastatic prostate cancer patients are treated – improving the patients' quality of life as they navigate their treatment options.
- Together they will change the way metastatic prostate cancer patients are treated – improving the patients' quality of life as they navigate their treatment options.
- BioAro will be providing complimentary genomic testing services for up to 100 eligible patients referred through specific Urologists of the Southern Alberta Institute of Urology (SAIU).
- This is the first-time genomic testing, analysis and support for companion diagnostics of this magnitude has been offered at no cost to AB cancer patients from a local company.
- BioAro Inc. is proud to undertake this initiative with the PCC to give the gift of equitable GenOMIC testing and information to prostate cancer families in need.